NCT01836874View on ClinicalTrials.gov

A Study of Prophylaxis for Migraine Patients With Topiramate in India

CompletedOBSERVATIONAL
Enrollment

209

Participants

Timeline

Start Date

May 31, 2007

Primary Completion Date

July 31, 2008

Study Completion Date

July 31, 2008

Conditions
Migraine
Interventions
DRUG

No intervention

This is an observational study. Participants receiving topiramate 25 mg once-a-day for 1 week and later on, receiving increase dose up to 200 mg, twice-a-day, orally will be observed for 3 months.

All Listed Sponsors
lead

Janssen-Cilag Ltd.

INDUSTRY

NCT01836874 - A Study of Prophylaxis for Migraine Patients With Topiramate in India | Biotech Hunter | Biotech Hunter